Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rie Makuuchi"'
Autor:
Satoshi Ida, Koshi Kumagai, Rie Makuuchi, Naoki Hiki, Takeshi Sano, Yosuke Kano, Souya Nunobe, Manabu Ohashi
Publikováno v:
Gastric Cancer. 23:927-936
Whether splenectomy for splenic hilar lymph node (No. 10) dissection in type 4 gastric cancer involving the greater curvature is necessary is not established. Patients with type 4 gastric cancer often experience peritoneal relapse, despite curative s
Autor:
Yutaka Tanizawa, Etsuro Bando, Tomoyuki Irino, Raito Asaoka, Masanori Terashima, Rie Makuuchi, Taiichi Kawamura
Publikováno v:
Gastric Cancer. 22:413-420
Hospital readmission is gathering greater attention as a measure of health care quality. The introduction of fast-track surgery has led to shorter lengths of hospitalization without increasing the risk of postoperative complications and readmission.
Autor:
Noboru Kawata, Yutaka Tanizawa, Naomi Kakushima, Keiichi Fujiya, Masanori Tokunaga, Etsuro Bando, Rie Makuuchi, Makoto Hikage, Masanori Terashima, Taiichi Kawamura, Kohei Takizawa, Masaki Tanaka, Hiroyuki Ono
Publikováno v:
Gastric Cancer. 21:124-132
The standard treatment for clinical submucosal invasive (cT1b) early gastric cancer is gastrectomy. However, Japanese gastric cancer treatment guidelines list endoscopic submucosal dissection (ESD) as an option for treating limited early gastric canc
Autor:
Wataru Takagi, Hayato Omori, Keiichi Fujiya, Yutaka Tanizawa, Noriyuki Nishiwaki, Fumiko Hirata, Masanori Tokunaga, Rie Makuuchi, Taiichi Kawamura, Etsuro Bando, Masanori Terashima, Makoto Hikage
Publikováno v:
Gastric Cancer. 20:141-149
There is no evidence that strict follow-up using cross-sectional imaging after curative gastrectomy benefits survival; however, nonperitoneal recurrence detected early might be treated with additional surgery. The present study examined whether early
Autor:
Rie Makuuchi, Taiichi Kawamura, Etsuro Bando, Masanori Tokunaga, Yutaka Tanizawa, Masanori Terashima
Publikováno v:
Gastric Cancer. 20:448-456
Preoperative clinical staging of gastric cancer is used to determine therapeutic strategies. However, the impact of the clinical stage on survival has not been completely investigated, although the relationship between pathologic staging and survival
Autor:
Rie Makuuchi, Takahiro Kinoshita, Takeo Fukagawa, Ryohei Kawabata, Hiroaki Hata, Manabu Ohashi, Kazuhide Higuchi, Hitoshi Katai, Masaki Aizawa, Jun Hihara, Kengo Nagashima, Takeshi Sakamoto, Narikazu Boku, Tatsuya Yamada, Keitaro Tashiro, Toshifumi Yamaguchi, Atsuo Takashima, Yasuyuki Kawachi, Toshikatsu Tsuji
Publikováno v:
Annals of surgical oncology. 27(1)
Gastric cancer (GC) patients with positive peritoneal lavage cytology (CY1) and/or localized peritoneum metastasis (P1a) are defined as stage IV in the 15th edition of the Japanese Classification of Gastric Cancer. In Japan, the most common treatment
Autor:
Yutaka Tanizawa, Makoto Hikage, Masanori Terashima, Norihiko Sugisawa, Taiichi Kawamura, Masanori Tokunaga, Etsuro Bando, Sanae Kaji, Rie Makuuchi
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 43(1)
We previously reported on the feasibility of enhanced recovery after surgery (ERAS) protocol for gastric cancer with a prospective phase II study, but the superiority of this approach over non-ERAS perioperative management remains unclear. Preoperati
Autor:
Yuichiro Miki, Taiichi Kawamura, Norihiko Sugisawa, Masanori Terashima, Masanori Tokunaga, Yutaka Tanizawa, Rie Makuuchi, Etsuro Bando
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 19(3)
The enhanced recovery after surgery (ERAS) protocol integrates a number of perioperative interventions and techniques, aiming at decreasing the morbidity rate and the length of postoperative hospital stay after surgery. Although it has become a stand